Evidence map›Paper›PMID 36458907›Full record

ArticleChemical research in toxicology2022

An End Point-Specific Framework for Read-Across Analog Selection for Human Health Effects.

Holger Moustakas, Mihir S Date, Manoj Kumar, Terry W Schultz, Daniel C Liebler, Trevor M Penning, Daniel T Salvito, Anne Marie Api

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Incorporating new approach methods (NAMs) data in dose-response assessments: The future is now!Journal of toxicology and environmental health. Part B, Critical reviews · 2025
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Holger MoustakasResearch Institute of Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, New Jersey 07677, United States.ORCID 0000-0003-2895-1695
Mihir S DateRoivant Sciences, 151 W 42 St, 15th Floor, New York, New York 10036, United States.
Manoj KumarMars Advanced Research Institute, Mars Incorporated, 110 Edison Pl, Newark, New Jersey 07102, United States.
Terry W SchultzThe University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, Tennessee 37996-4500, United States.
Daniel C LieblerDepartment of Biochemistry, Vanderbilt University, B3301A Medical Center North 465 21st Avenue South, Nashville, Tennessee 37232-6350, United States.ORCID 0000-0002-7873-3031
Trevor M PenningCenter of Excellence in Environmental Toxicology, The University of Pennsylvania, Perelman School of Medicine, 1315 Biomedical Research Building (BRB) II/III, 421 Curie Boulevard, Philadelphia, Pennsylvania 19104-3083, United States.ORCID 0000-0002-3937-1066
Daniel T SalvitoResearch Institute of Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, New Jersey 07677, United States.
Anne Marie ApiResearch Institute of Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, New Jersey 07677, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating computational chemistry and toxicology can improve the read-across analog approach to fill data gaps in chemical safety assessment. In read-across, structure-related parameters are compared between a target chemical with insufficient test data and one or more materials with sufficient data. Recent advances have focused on enhancing the grouping or clustering of chemicals to facilitate toxicity prediction via read-across. Analog selection ascertains relevant features, such as physical-chemical properties, toxicokinetic-related properties (bioavailability, metabolism, and degradation pathways), and toxicodynamic properties of chemicals with an emphasis on mechanisms or modes of action. However, each human health end point (genotoxicity, skin sensitization, phototoxicity, repeated dose toxicity, reproductive toxicity, and local respiratory toxicity) provides a different critical context for analog selection. Here six end point-specific, rule-based schemes are described. Each scheme creates an end point-specific workflow for filling the target material data gap by read-across. These schemes are intended to create a transparent rationale that supports the selected read-across analog(s) for the specific end point under study. This framework can systematically drive the selection of read-across analogs for each end point, thereby accelerating the safety assessment process.

Indexed as

PerfumeDNA DamageHumansRisk AssessmentToxicity TestsPerfume

Identifiers

PMID36458907
PMCPMC9768807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.